Evéquoz D, Aubert J F, Nussberger J, Biollaz J, Diezi J, Brunner H R, Waeber B
Division of Hypertension, University of Lausanne, Switzerland.
Nephron. 1996;73(3):467-72. doi: 10.1159/000189112.
Neuropeptide Y (NPY) is a vasoconstrictor peptide possibly involved in the regulation of renal sodium handling and renin release. This investigation was undertaken to assess in conscious normotensive rats the acute effects of a non-pressor dose of NPY on renal plasma flow, glomerular filtration rate, sodium excretion and plasma renin activity. Experiments were also performed during concomitant beta-adrenoceptor stimulation with isoproterenol. NPY per se had no effect on the studied parameters. Renal plasma flow was increased by isoproterenol and was significantly higher when the beta-adrenoceptor stimulant was infused alone (13.4 +/- 2.1 ml/min, p < 0.05, mean +/- SEM) that when administered together with NPY (7.2 +/- 2.0 ml/min). This was also true for glomerular filtration rate (3.3 +/- 0.3 vs. 1.8 +/- 0.3 ml/min, p < 0.01) and plasma renin activity (6.3 +/- 1.7 vs. 2.1 +/- 0.4 ng Ang I/ml/h, p < 0.05). Our data however do not allow to deduce whether the inhibitory effect of NPY on isoproterenol-induced renin release is mediated by changes in intrarenal hemodynamics or a direct effect on juxtaglomerular cells.
神经肽Y(NPY)是一种血管收缩肽,可能参与肾钠处理和肾素释放的调节。本研究旨在评估在清醒的正常血压大鼠中,非升压剂量的NPY对肾血浆流量、肾小球滤过率、钠排泄和血浆肾素活性的急性影响。实验还在同时用异丙肾上腺素刺激β-肾上腺素受体时进行。NPY本身对所研究的参数没有影响。异丙肾上腺素可增加肾血浆流量,单独输注β-肾上腺素受体兴奋剂时肾血浆流量显著更高(13.4±2.1毫升/分钟,p<0.05,平均值±标准误),而与NPY一起给药时为(7.2±2.0毫升/分钟)。肾小球滤过率(3.3±0.3对1.8±0.3毫升/分钟,p<0.01)和血浆肾素活性(6.3±1.7对2.1±0.4纳克血管紧张素I/毫升/小时,p<0.05)也是如此。然而,我们的数据无法推断NPY对异丙肾上腺素诱导的肾素释放的抑制作用是由肾内血流动力学变化介导的,还是对肾小球旁细胞的直接作用。